▲ BUY
5
/ 10
Conviction
$ Value
$87K
Shares
20,000
Price
$4
Filed
Jan 14
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Feinberg Peter
Title
—
CIK
0001870076
Roles
Director
Transaction Details
Transaction Date
2026-01-12
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
135,441
Footnotes
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.315 to $4.38. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
Filing Info
Feinberg Peter's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-12 | IMRX | ▲ | $87K ★ |
| 2026-01-01 | IMRX | A | $0 |
| 2025-10-03 | IMRX | ▲ | $50K |
| 2025-09-30 | IMRX | ▲ | $53K |
| 2025-09-29 | IMRX | ▲ | $36K |
| 2025-06-18 | IMRX | ▲ | $63K |
| 2025-06-13 | IMRX | A | $0 |
Other Insiders at IMRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Matushansky Igor
Chief Medical Officer
|
— | — | 2026-02-03 |
|
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
|
— | — | 2026-02-03 |
|
Zeskind Benjamin J.
PRESIDENT AND CEO
|
— | — | 2026-02-03 |
|
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-02-03 |
|
Morales Mallory
SVP Finance, CAO
|
— | — | 2026-02-03 |
|
Neufeld Leah R
CHIEF PEOPLE OFFICER
|
— | — | 2026-02-03 |
|
Brakewood Harold Eugene
Chief Business Officer
|
— | — | 2026-02-03 |